BIZILY SCOTT (Chief Legal Officer) sold 24.0% of their position (1.64K shares) of 4D MOLECULAR THERAPEUTICS, INC. on the open market
Open‑market sale worth $16.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/20/2025ACC: 0001193125-25-243946
Officer· Chief Legal Officer
Since Mar 2022
-1.64K
Net shares
Net seller
$16.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.64K acquired · 3.27K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.64K
Price / share
$4.14
Trade value
$6.77K
% of position
31.5%
10/16/2025
5.19K→6.82K
Common Stock
Direct
Shares
−1.64K
Price / share
$10.17
Trade value
$16.63K
% of position
24.0%
10/16/2025
6.82K→5.19K
Total
Net shares
+0.00
Net value
-$9.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/16/2025 | M · Option Exercise | +1.64K | $4.14 | $6.77K | 31.5% | 5.19K | 6.82K |
| Common Stock Direct | 10/16/2025 | S · Sale | −1.64K | $10.17 | $16.63K | 24.0% | 6.82K | 5.19K |
| Total | +0.00 | -$9.86K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.64K shares
Shares
−1.64K
Strike price
4.14
Held after
76.86K
Exercisable
—
10/16/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.64K shares | 10/16/2025 | M · Option Exercise | −1.64K | 4.14 | — | 76.86K |